Bauer E A, Uitto J, Tan E M, Holbrook K A
Division of Dermatology, Washington University School of Medicine, St Louis, MO 63110.
Arch Dermatol. 1988 Jan;124(1):90-101. doi: 10.1001/archderm.124.1.90.
We describe a patient with Werner's syndrome from whom skin biopsy specimens were sampled for histology and electron microscopy and fibroblasts were cultured. Tissue sampled from five sites that varied in clinical presentation revealed striking changes in the dermoepidermal junction, elastic fibers of the papillary and reticular dermis, and adipose tissue of the hypodermis. The density and organization of the collagenous connective tissue was altered variably depending on the biopsy site. Changes noted in the epidermis were indicative of tissue regeneration and repair. Cells derived from acral areas grew poorly and could not be passed. Collagen synthesis in these cells was enhanced approximately 50%, and collagenase expression was decreased to a similar degree. Cells derived from the skin of the trunk could be passed but had an abbreviated in vitro life span. Collagen synthesis in these cells was unaltered. Serum from the patient with Werner's syndrome or from his obligate heterozygote offspring stimulated collagen synthesis in low-passage normal human skin fibroblast target cells. Sequential passage of these normal cells resulted in a blunting of the stimulatory effect. These observations suggest that a stimulator of collagen synthesis exists in the serum of patients with Werner's syndrome and that as cells (either normal or Werner's syndrome) "age" in vitro they may become hyporesponsive to this as yet undefined stimulatory factor in serum.
我们描述了一名患有沃纳综合征的患者,从其身上获取皮肤活检标本用于组织学和电子显微镜检查,并培养了成纤维细胞。从临床表现各异的五个部位采集的组织显示,真皮表皮连接处、乳头层和网状真皮的弹性纤维以及皮下脂肪组织有显著变化。胶原结缔组织的密度和组织结构因活检部位不同而有不同程度的改变。表皮中观察到的变化表明组织正在再生和修复。来自肢端部位的细胞生长不佳,无法传代。这些细胞中的胶原合成增加了约50%,胶原酶表达下降到相似程度。来自躯干皮肤的细胞可以传代,但体外寿命缩短。这些细胞中的胶原合成未改变。沃纳综合征患者或其 obligate 杂合子后代的血清刺激低代正常人皮肤成纤维细胞靶细胞中的胶原合成。这些正常细胞的连续传代导致刺激作用减弱。这些观察结果表明,沃纳综合征患者血清中存在一种胶原合成刺激物,并且随着细胞(正常细胞或沃纳综合征细胞)在体外“老化”,它们可能对血清中这种尚未明确的刺激因子反应性降低。